诺瓦瓦克斯医药 | 8.33 -0.26 -3.03% | ||
| NVAX | |||
| 高 8.69 | 开 8.61 | 量 451.94万股 | 总市值 13.53亿 |
| 低 8.24 | 换 2.78% | 额 3790.71万 | 市盈TTM 3.20 |
分时
5日
日K
周K
月K
季K
年K
诺瓦瓦克斯医药(NVAX)
10-07 19:05
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-25-097317 Act: 34 Size: 236 KB 网页链接
诺瓦瓦克斯医药(NVAX)
08-28 04:45
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-25-084049 Act: 34 Size: 232 KB 网页链接
诺瓦瓦克斯医药(NVAX)
08-28 04:45
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 1.01, 2.03, 3.02, and 9.01 Accession Number: 0001104659-25-084053 Act: 34 Size: 1 MB 网页链接
诺瓦瓦克斯医药(NVAX)
08-21 19:55
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001104659-25-081160 Act: 34 Size: 379 KB 网页链接
诺瓦瓦克斯医药(NVAX)
08-06 20:05
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001000694-25-000031 Act: 34 Size: 311 KB 网页链接
诺瓦瓦克斯医药(NVAX)
08-06 19:55
$诺瓦瓦克斯医药(NVAX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001000694-25-000029 Act: 34 Size: 10 MB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062192 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062191 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062193 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062195 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062196 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062194 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-24 18:05
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, item 5.07 Accession Number: 0001104659-25-061874 Act: 34 Size: 194 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-17 04:15
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-25-000783 Size: 6 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-17 04:15
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-25-000784 Size: 6 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-14 09:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-25-000758 Size: 6 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-14 09:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-25-000760 Size: 6 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-14 09:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-25-000757 Size: 6 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-14 09:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-25-000759 Size: 6 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-11 19:05
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-25-058379 Act: 34 Size: 16 MB 网页链接